Institute For Orphan and Rare Diseases

How can AdInfer^© artificial intelligence (AI) system help address challenges associated with the study of rare diseases?

• Screen large numbers of individuals from the general population worldwide through a digital platform
• Screen patients and families through large network of clinic satellite centers
• Collect large number of variables allowing to identify symptoms, patterns, and associations that may not have been seen otherwise
• Generate new hypotheses in the understanding of the disease, and/or for the development of treatments
• Potentially allow for an earlier diagnosis
• Contribute to clinical trials by providing an easier and more representative recruitment of subjects, the collect of large numbers of variables and by facilitation follow-ups and longitudinal studies
More about AdInfer